Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Payables (2017 - 2025)

Selectis Health's Payables history spans 13 years, with the latest figure at $7.3 million for Q3 2025.

  • For Q3 2025, Payables rose 11.48% year-over-year to $7.3 million; the TTM value through Sep 2025 reached $7.3 million, up 11.48%, while the annual FY2024 figure was $6.6 million, 5.0% down from the prior year.
  • Payables for Q3 2025 was $7.3 million at Selectis Health, down from $8.0 million in the prior quarter.
  • Across five years, Payables topped out at $8.9 million in Q1 2025 and bottomed at $179071.0 in Q4 2021.
  • The 5-year median for Payables is $5.2 million (2023), against an average of $5.2 million.
  • The largest YoY upside for Payables was 2022.9% in 2022 against a maximum downside of 27.81% in 2022.
  • A 5-year view of Payables shows it stood at $179071.0 in 2021, then surged by 2022.9% to $3.8 million in 2022, then soared by 83.51% to $7.0 million in 2023, then decreased by 5.0% to $6.6 million in 2024, then rose by 9.92% to $7.3 million in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Payables are $7.3 million (Q3 2025), $8.0 million (Q2 2025), and $8.9 million (Q1 2025).